Yanjun Zheng Selected Research

Yanjun Zheng Research Topics

Disease

7	Neoplasms (Cancer) 02/2022 - 03/2011
5	Infarction (Infarctions) 04/2022 - 02/2015
3	Hypoxia (Hypoxemia) 08/2019 - 03/2011
2	Insulin Resistance 11/2021 - 01/2017
2	Reperfusion Injury 11/2020 - 01/2017
2	Myocardial Ischemia (Ischemic Heart Diseases) 11/2020 - 08/2019
2	Ischemia 01/2020 - 01/2017
1	Liver Neoplasms (Liver Cancer) 02/2022
1	Inflammation (Inflammations) 01/2022
1	Glioma (Gliomas) 01/2022
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2021
1	Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal) 01/2021
1	Sepsis (Septicemia) 01/2021
1	Moyamoya Disease (Moya-Moya Disease) 01/2020
1	Breast Neoplasms (Breast Cancer) 01/2020
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2020
1	Carcinoma (Carcinomatosis) 01/2020
1	Hepatocellular Carcinoma (Hepatoma) 10/2018
1	Neoplasm Metastasis (Metastasis) 10/2018
1	Non-alcoholic Fatty Liver Disease 01/2018
1	Thyroid Diseases (Thyroid Disease) 12/2017
1	Type 2 Diabetes Mellitus (MODY) 01/2017
1	Hemorrhage 11/2016
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2014
1	Stomach Neoplasms (Stomach Cancer) 03/2011

Drug/Important Bio-Agent (IBA)

3	Long Noncoding RNAIBA 01/2021 - 10/2018
2	Transcription Factors (Transcription Factor)IBA 01/2022 - 01/2020
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2018
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 11/2020 - 02/2015
2	Proteins (Proteins, Gene)FDA Link 01/2016 - 01/2014
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2016 - 03/2011
1	RNA (Ribonucleic Acid)IBA 04/2022
1	Tumor Biomarkers (Tumor Markers)IBA 02/2022
1	Leucyl Aminopeptidase (Peptidase S)IBA 02/2022
1	Pharmaceutical PreparationsIBA 01/2022
1	Immune Checkpoint InhibitorsIBA 01/2022
1	Follicle Stimulating Hormone (Follitropin)FDA Link 11/2021
1	Dehydroepiandrosterone SulfateIBA 11/2021
1	Progesterone FDA LinkGeneric 11/2021
1	MicroRNAs (MicroRNA)IBA 01/2021
1	AndrogensIBA 01/2021
1	Messenger RNA (mRNA)IBA 01/2021
1	Mechanistic Target of Rapamycin Complex 1IBA 11/2020
1	purineIBA 01/2020
1	pinocembrinIBA 01/2020
1	Competitive Endogenous RNAIBA 01/2020
1	Circular RNAIBA 08/2019
1	Small Interfering RNA (siRNA)IBA 10/2018
1	iodized salt (iodised salt)IBA 12/2017
1	IodineIBA 12/2017
1	hydroxide ionIBA 01/2017
1	berbamine (penduline)IBA 01/2017
1	Vitamin D FDA LinkGeneric 01/2017
1	Polypropylenes (Polypropylene)IBA 11/2016
1	NestinIBA 01/2016
1	VimentinIBA 01/2016
1	cadherin 5IBA 01/2016
1	Cadherins (E-Cadherin)IBA 01/2016
1	CaspasesIBA 01/2016
1	CateninsIBA 01/2016
1	CalciumIBA 01/2016
1	ChromatinIBA 03/2011
1	eupatilinIBA 03/2011
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 03/2011
1	Aryl Hydrocarbon Receptor Nuclear TranslocatorIBA 03/2011

Therapy/Procedure

2	Therapeutics 02/2022 - 01/2022
2	Immunotherapy 01/2022 - 01/2021
1	Ligation 01/2021
1	Punctures 01/2021
1	Operative Time 11/2016
1	Sutures (Suture) 11/2016